Last reviewed · How we verify
NCT05998720
Application of New Magnetic Resonance UTE Technique in Hip Joint Lesions
trial in Hip Disease in 150 participants. Status unknown.
13 June 2024
Quick facts
| Lead sponsor | Fifth Affiliated Hospital, Sun Yat-Sen University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 July 2023 |
| Primary completion | 13 June 2024 |
| Estimated completion | 13 June 2024 |
| Sites | 1 location across China |
Conditions studied
- Hip Disease — all drugs for Hip Disease →
Sponsor
Fifth Affiliated Hospital, Sun Yat-Sen University
Who can join
Eligibility, any sex, with Hip Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Explore the imaging and quantitative monitoring of hip bone, cartilage and ligament by magnetic resonance UTE technology, combined with QCT and DXA technology, to provide a more accurate basis for clinical evaluation and treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05998720
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hip Disease
Currently open trials in the same condition.
- NCT07023094 — PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery · Phase 4 · recruiting
- NCT07147530 — Effectiveness and Safety of the Electrically Powered Orthopedic Exercise Device on Gait Ability in Patients With Hip Joi · Phase 4 · recruiting
- NCT06153940 — Everglade Stem, World Cup and World Liner Post Market Clinical Follow-up · recruiting
- NCT04028687 — MDR - PMCF Study for Taperloc Complete Stems · recruiting
Other Fifth Affiliated Hospital, Sun Yat-Sen University trials
Trials by the same sponsor.
- NCT06079931 — The Efficacy of Babaodan Capsules in Preventing Radiation Pneumonia · Phase 2 · unknown
- NCT06525025 — Building a Traditional Chinese Medicine Clinical Diagnosis and Treatment Database · not yet recruiting
- NCT06060782 — Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine · Phase 1 · recruiting
- NCT06220552 — The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma · Phase 2 · recruiting
- NCT06147947 — Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05998720 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fifth Affiliated Hospital, Sun Yat-Sen University
- Last refreshed: 21 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05998720.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing